Patents by Inventor David N Jackson

David N Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210170118
    Abstract: A pulmonary inhaler includes a dual-action “child-proof” lock that requires more than one manual action to unlock the inhaler to allow the user to perform the dispensing action. For example, the user may press a small button on the back of the lower housing while rotating the upper housing with respect to the lower housing. These separate user actions performed simultaneously to unlock the inhale are is difficult for a child to perform accidentally. This rotation also moves an integral door that covers the mouthpiece aperture. The integral mouthpiece door, which prevents debris from getting inside the inhaler when it is locked, avoids the need for separate cap or tethered mouthpiece cover. The dual-action locking feature requires a minimal number of parts and provides an easily visible indication that the actuator is in the “locked” state or the “unlocked” state.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 10, 2021
    Inventors: David N. Jackson, Russel M. Smith
  • Publication number: 20200001027
    Abstract: Security features for an electronic metered-dose smart inhaler, mobile app, and cloud-based software system for use with medical prescriptions and clinical trial regimens. The smart inhaler requires several types of user validation and feedback, and enters a locked-out state when required user feedback is not received or when received user feedback raises a suspicion of fraudulent or improper use. While the smart inhaler system is well suited for aerosol medical marijuana products, it may be used to deliver and conduct clinical trials on any type of product suitable for aerosol administration including other types of medication and non-medical products, such as nicotine, herbal products, pain killers, sleep aids, dietary stimulants, dietary suppressants, etc. The security features are not limited to aerosol inhalers, and may be applied more widely to other types of in-home, patient-administered products.
    Type: Application
    Filed: September 12, 2019
    Publication date: January 2, 2020
    Inventors: David N. Jackson, Russell M. Smith
  • Patent number: 10449310
    Abstract: Security features for an electronic metered-dose smart inhaler, mobile app, and cloud-based software system that validates users and inhaler use protocols, such as medical prescriptions and clinical trial regimens. The smart inhaler interacts with a mobile app to control and monitor per-dose usage and capture efficacy results and feedback from medical patients and clinical trial participants for review by prescribing physicians, clinical trial administrators, medicine formulators and artificial intelligence. While the smart inhaler system is well suited for aerosol medical marijuana products, it may be used to deliver and conduct clinical trials on any type of product suitable for aerosol administration including other types of medication and non-medical products, such as nicotine, herbal products, pain killers, sleep aids, dietary stimulants, dietary suppressants, etc.
    Type: Grant
    Filed: February 7, 2019
    Date of Patent: October 22, 2019
    Assignee: Optimist Inhaler LLC
    Inventors: David N Jackson, Russell M Smith
  • Publication number: 20190240430
    Abstract: Security features for an electronic metered-dose smart inhaler, mobile app, and cloud-based software system that validates users and inhaler use protocols, such as medical prescriptions and clinical trial regimens. The smart inhaler interacts with a mobile app to control and monitor per-dose usage and capture efficacy results and feedback from medical patients and clinical trial participants for review by prescribing physicians, clinical trial administrators, medicine formulators and artificial intelligence. While the smart inhaler system is well suited for aerosol medical marijuana products, it may be used to deliver and conduct clinical trials on any type of product suitable for aerosol administration including other types of medication and non-medical products, such as nicotine, herbal products, pain killers, sleep aids, dietary stimulants, dietary suppressants, etc.
    Type: Application
    Filed: February 7, 2019
    Publication date: August 8, 2019
    Inventors: David N Jackson, Russell M Smith
  • Patent number: D863531
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 15, 2019
    Assignee: Optimist Inhaler LLC
    Inventors: David N Jackson, Russell M Smith
  • Patent number: D863532
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 15, 2019
    Assignee: Optimist Inhaler LLC
    Inventors: David N. Jackson, Russell M Smith
  • Patent number: D863533
    Type: Grant
    Filed: January 4, 2019
    Date of Patent: October 15, 2019
    Assignee: Optimist Inhaler LLC
    Inventors: David N. Jackson, Russell M Smith
  • Patent number: D863534
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: October 15, 2019
    Assignee: Optimist Inhaler LLC
    Inventors: David N Jackson, Russell M Smith
  • Patent number: D877322
    Type: Grant
    Filed: August 3, 2019
    Date of Patent: March 3, 2020
    Assignee: Optimist Inhaler, LLC
    Inventors: David N Jackson, Russell M Smith